Immune‐related adverse events predict responses to <scp>PD</scp>‐1 blockade immunotherapy in hepatocellular carcinoma
Lianghe Lu(Sun Yat-sen University), Muyan Cai(Sun Yat-sen University), Yihong Ling(Sun Yat-sen University), Kaili Xing(Sun Yat-sen University), Dan Xie(The Eighth Hospital of Xi'an), Yan Wang(Chengdu Medical College), Wei Wei(Zhujiang Hospital), Shaohua Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Peng Li(Chinese Academy of Sciences), Rong Guo(Sun Yat-sen University)
Cited by 27
Related Papers
N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis
|Nature Communications|2019|836
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
Establishment of porcine and human expanded potential stem cells
|Nature Cell Biology|2019|411